Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS)

This study has been terminated.
(Slow recruitment)
Sponsor:
Collaborators:
Roche Pharma AG
Genentech
Information provided by (Responsible Party):
Lisa Bax, Cambridge University Hospitals NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT01096732
First received: March 30, 2010
Last updated: January 7, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2012
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)